Order Plinest® Hair for Clinics

Plinest® Hair is a professional PN-HPT polynucleotide injectable supplied for clinician-directed scalp and eyebrow protocols. Licensed clinics and healthcare professionals can order the 2mL prefilled syringe presentation for treatment-room use, with two 30G 1/2 needles included for procedure setup. The unit is designed for intradermal administration by trained providers using clinic-approved technique, documentation, and aseptic handling standards.

Plinest Hair 2mL Injectable: Form, Strength, and Pack Details

Plinest Hair 2mL is supplied as a single-use prefilled syringe containing polynucleotides 15 mg/2 mL in a polymerized gel matrix. The format helps clinics plan tray setup, patient-room turnover, and lot documentation without transferring product from a separate vial. Although some teams search for Plinest Hair vials, Plinest Hair ampoules, or a Plinest Hair single vial, this unit is described as a 1 x 2mL prefilled syringe with two included needles.

The prefilled syringe format may reduce non-sterile handling steps compared with drawing from a separate container. It also gives administrators a clear unit count for service-line planning. For broader category planning, clinics can review adjacent professional supplies in Hair Loss and Mesotherapy.

Clinic Ordering, Price Visibility, and Account Access

Current prices and quantity breaks are shown on this page, and licensed clinics can order as a guest or with an account.

Med Wholesale Supplies supports professional accounts with brand-name medical products sourced through vetted distributors and verified supply channels. Clinic documentation may be requested before shipment, especially when a facility is onboarding a new injectable category or establishing a multi-provider service line. Orders are supported with temperature-controlled handling when required and tracked US delivery.

Quick tip: Match the number of 2mL syringes to confirmed appointment blocks and keep lot numbers tied to the patient record.

How PN-HPT Supports Scalp and Eyebrow Protocols

Plinest Hair PN-HPT contains polymerized polynucleotides in a viscoelastic gel. Polynucleotides are nucleic-acid-derived biopolymers used in aesthetic and regenerative-style workflows for tissue support. In clinic use, the gel matrix provides controlled extrusion and a hydrated microenvironment suitable for intradermal microinjection techniques.

Clinics typically position a polynucleotide scalp treatment within structured programs focused on scalp quality, tissue conditioning, and procedural consistency. The product may be used in hair-bearing scalp and eyebrow areas when a trained healthcare professional determines that a PN-HPT scalp injection fits the protocol. The copy here does not provide dosing, injection maps, spacing, or treatment intervals; those decisions belong in provider training, manufacturer guidance, and internal medical protocols.

Many search results discuss hair growth outcomes in broad consumer terms. For clinic purchasing, the practical question is whether the product fits a supervised protocol, whether the presentation supports efficient sterile setup, and whether staff can document use consistently. For educational context on treatment sequencing, see mesotherapy for hair protocols and the discussion of hair fillers for hair loss.

Professional Applications and Treatment-Room Fit

Aesthetic clinics, dermatology-led trichology services, and physician-directed med spas may incorporate Plinest Hair injection into scalp rejuvenation or brow-focused workflows. The included fine-gauge needles support common microinjection tray planning, although providers may select alternate supplies when their approved technique requires them. The single-use unit helps staff stage materials, document lot and expiry, and maintain a predictable product count per session.

Plinest Hair may also sit within a broader plan that includes microneedling, PRP, device-based stimulation, topical care, or other professional adjuncts. Sequencing should be set by the supervising provider because product compatibility, treatment spacing, and post-procedure instructions can vary by clinic policy and patient factors. Teams evaluating multiple procedural categories can also browse Skin Boosters for related aesthetic workflow planning.

• Prefilled 2mL syringe supports efficient tray staging.
• Two 30G 1/2 needles are included in the box.
• Lot and expiry labeling supports chart documentation.
• Single-use presentation helps maintain clean inventory accounting.
• Gel rheology supports controlled intradermal placement by trained injectors.
• Scalp and eyebrow positioning fits clinician-directed hair-focused protocols.

Composition, Handling, and Documentation

The active component is polynucleotides 15 mg/2 mL in a polymerized gel matrix. No anesthetic agent is identified among the active components in the supplied materials. Clinics should review the carton, syringe label, and package insert before use, because the label is the controlling source for storage, expiry, compatibility, and procedural precautions.

As with any sterile injectable, staff should protect the sterile field, inspect packaging before setup, and use the unit for one patient encounter only. Record the lot number, expiry, presentation, and provider according to facility policy. If the clinic keeps multiple PN-HPT or hair injectable products on hand, separate storage bins and clear SKU naming can reduce mix-ups during high-volume procedure days.

Why it matters: The 2mL prefilled syringe format gives both injectors and inventory staff a defined unit for scheduling, charting, and reordering.

Safety, Contraindications, and Professional Precautions

Plinest Hair is intended for professional administration, not self-injection. A qualified clinician should assess suitability before treatment, including relevant medical history, scalp condition, infection risk, hypersensitivity history, current medications, and planned adjunctive procedures. Do not inject through infected, inflamed, or compromised tissue, and follow the manufacturer’s contraindications and local scope-of-practice requirements.

Expected procedure-related effects for intradermal scalp injections may include transient discomfort, redness, swelling, pinpoint bleeding, tenderness, bruising, or localized irritation. More serious concerns, such as infection, allergic reaction, vascular compromise, or persistent inflammation, require prompt clinical evaluation. Clinics should give patients clear post-procedure instructions and an escalation pathway for symptoms that fall outside the expected recovery pattern.

Compatibility with other treatments should be decided before the session. When PN-HPT is paired with PRP, microneedling, exosome-based protocols, or energy devices, the supervising provider should define timing, cleansing steps, needle selection, and aftercare. Staff training should include adverse-event recognition, aseptic preparation, sharps disposal, and recordkeeping requirements.

Inventory Planning for Hair-Focused Service Lines

Plinest Hair 1x2mL gives administrators a simple countable unit for booking templates. Clinics can forecast consumption by looking at provider schedules, average session frequency, and whether the product is used alone or as part of a combined scalp plan. Because packaging includes the syringe and two needles, tray lists can be standardized for assistants while still allowing injector preference for additional supplies.

Reorder timing should account for lot tracking, staff training, promotional scheduling, and intake variability. If the exact SKU is temporarily constrained, confirm any substitution against clinic protocols before switching. A comparable product may differ in syringe design, concentration, included accessories, viscosity, or intended technique, so substitution should never be handled as a purely administrative decision.

Some teams keep related hair injectables on formulary to maintain service continuity. For product-level comparison, clinics may evaluate Croma PhilArt Hair, Nucleofill Hair, or Dr. CYJ Hair Filler. Use presentation, concentration, handling, and provider familiarity as the comparison points.

Related Plinest and Adjacent Products

Plinest Hair is the hair-focused member of the Plinest portfolio described here. Clinics building a broader polynucleotide offering may also evaluate Plinest for wider aesthetic use or Plinest Fast when their protocols call for a different presentation within the same product family. Keep each SKU separated in treatment menus, consent language, and storage labels to avoid confusion during room setup.

When comparing polynucleotide hair injectables, focus on the exact presentation rather than search labels such as kit, ampoules, or vials. Plinest Hair is a 2mL prefilled syringe unit with two 30G needles. Other products may use different formats, volumes, or accessories, and those differences can affect appointment staging, product allocation, and injector technique.

Common Clinic Questions About Results and Positioning

Clinics often ask whether Plinest Hair “works” for every hair-loss presentation. The responsible answer is that a polynucleotide injectable may support scalp-conditioning protocols, but outcomes depend on diagnosis, patient selection, technique, treatment sequencing, and the presence of medical causes of shedding or thinning. Providers should assess androgenetic alopecia, inflammatory scalp disease, nutritional contributors, medication history, postpartum shedding, and other relevant factors before positioning any injectable service.

Questions about celebrity hair-loss stories or the “most successful” hair regrowth product are not reliable purchasing criteria for a professional clinic. Evidence-based hair programs often combine diagnosis, medical management when appropriate, procedural adjuncts, and follow-up. Plinest Hair should be evaluated as a professional PN-HPT injectable within that broader clinical framework, not as a universal replacement for established medical or procedural options.

Authoritative Sources and Label Review

Before clinical use, review the manufacturer’s current labeling, package insert, carton information, and any training materials supplied through your professional channel. These documents should guide storage, inspection, contraindications, expiry, and administration precautions. Use peer-reviewed literature on polynucleotides only to inform clinical understanding; it should not replace product-specific labeling or provider judgment.

Internal protocols should define who may administer the product, how patients are assessed, what consent language is used, and how adverse events are handled. Documentation should include the treated area, lot number, expiry, syringe count, adjunctive procedures, and post-procedure instructions. This level of structure supports repeatable care and cleaner inventory control across multiple providers.

This content is for informational purposes only and is not a substitute for professional medical advice.